Market Overview

PCR Testing for Covid-19: Now is the Time

Share:

Dublin, April 07, 2020 (GLOBE NEWSWIRE) -- The "Covid-19 Testing: Now is the Time" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering.

To stop COVID-19 extensive testing is needed, in combination with continued shelter in place and selected quarantine response. PCR testing for COVID-19 works. PCR and molecular diagnostic tests are used to identify the virus that causes COVID-19. This is the type of test, along with molecular diagnostics, being used in the US to verify the presence of COVID-19 disease caused by the coronavirus. Countries that have used coronavirus testing in a thoughtful manner had much better success in controlling COVID-19 than the US. In order to deal with the pandemic in the US, better and more testing is needed.

The pandemic has a much higher death rate in the US than some other countries that have more testing. According to this report, the higher death rate is due to a lack of PCR testing and lack of quarantine. Social distancing is not enough. The virus is airborne and can spread to someone who is more than 6 feet away. Testing needs to be used in combination with isolation of those infected or who lack immunity and have been exposed. Only by knowing who has immunity - through testing- can we begin to get people back to work.

The virus can cause no symptoms and still spread - something not initially known. This makes it difficult to understand. It seems to be spread through the air and droplets from infected people. It seems to spread very easily from person to person. The pathogen is carried on tiny respiratory droplets that move through the air and fall eventually. The droplets come from a cough or sneeze. The virus may be transmitted by touching a contaminated surface and then touching the face.

Key Points in this PowerPoint:

  • Value of Testing for COVID-19
  • Abbott Labs Has 5 Minute COVID-19 Test
  • US COVID-19 Testing Equipment Market Description
  • Number of Tests Day, Tests per Week Capability
  • Time to Administer
  • Governor Cuomo Emerges as the Greatest
  • Serological Testing to See Who Has Immunity and Can Avoid Quarantine

Companies Mentioned

  • Abbott Labs
  • bioMrieux
  • CDC
  • Danaher/Cepheid
  • Danaher/IDT
  • Hologic
  • LabCorp
  • Mammoth
  • OPKO/BioReference
  • Quest Diagnostics
  • Roche
  • SunSure Biotech
  • Thermo Fisher

For more information about this report visit https://www.researchandmarkets.com/r/n4ancu

Source: Wintergreen Research, Inc

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
WLKCFRAUpgrades56.0
BRCB of A SecuritiesMaintains44.0
FIVEB of A SecuritiesMaintains120.0
ZMGuggenheimMaintains250.0
STNEGuggenheimMaintains45.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com